Lehman & Derafelo Financial Resources LLC Sorrento Therapeutics, Inc. Transaction History

Lehman & Derafelo Financial Resources LLC

  • $337 Million
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 20, 2021
SELL
$5.76 - $11.95 $17,856 - $37,045
-3,100 Closed
0 $0
Q3 2020

Nov 06, 2020
BUY
$6.17 - $18.82 $6,787 - $20,702
1,100 Added 55.0%
3,100 $35,000
Q2 2020

Jul 30, 2020
BUY
$1.73 - $6.76 $3,460 - $13,520
2,000 New
2,000 $13,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Lehman & Derafelo Financial Resources LLC Portfolio

Follow Lehman & Derafelo Financial Resources LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lehman & Derafelo Financial Resources LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lehman & Derafelo Financial Resources LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email